Form 4 for TWST Twist Bioscience Corp
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-04 · accession 0001214659-24-020033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-06 | 2024-12-04 | TWST | Leproust Emily M. | CEO, Dir | A - Grant | $0.00 | +95.3K | 676.9K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-04 | A | A | 95,350 | $0.00 | 676,934 | D | — | — | (F1) Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. |